Ȩ Ä«Å×°í¸® ¸ÂÃãÇü½ÃÀåÁ¶»ç ±¹Á¦ÄÁÆÛ·±½º ±Û·Î¹ú ÆÄÆ®³Ê ¸ÞÀϸµ ¼­ºñ½º ȸ»ç¼Ò°³È¸»ç¼Ò°³ Contact Us
English Japaness Chinese
Home > ½ÃÀ庸°í¼­ > ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö > ¹ÙÀÌ¿À¸ÅÆ®¸®¾ó > Japanese Markets for Orthopedic Biomaterials 2008
Ä«Å×°í¸®
¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö (1590)
°Ô³ð â¾à (202)
¸ÂÃãÇüÀÇ·á (51)
¹ÙÀÌ¿À¸¶Ä¿ (154)
¹ÙÀÌ¿À¸ÅÆ®¸®¾ó (54)
¹ÙÀÌ¿ÀÀåºñ (357)
ºÐÀÚÇ¥ÀûÄ¡·á(MTT) (131)
À¯ÀüÀÚ Ä¡·á/RNAi (101)
Àç»ýÀÇÇÐ (124)
Ç×ü/¸é¿ª (191)
½ÃÀ庸°í¼­

Japanese Markets for Orthopedic Biomaterials 2008

¸®¼­Ä¡»ç Millennium Research Group
¹ßÇàÀÏ 2008³â 04¿ù »óǰÄÚµå 71467
ÆäÀÌÁö Á¤º¸
°¡°Ý
US $ 3,077 £Ü 3,666,200 PDF by E-mail (Single user license)
US $ 4,620 £Ü 5,504,700 PDF by E-mail (Corporate license)


¿µ¹®¸ñÂ÷

Abstract

This market is comprised of hyaluronic acid, viscosupplementation and bone graft substitutes.

Table of Contents

1.0 ORTHOPEDIC BIOMATERIALS BACKGROUND

  • 1.1 Arthritis and Hyaluronic Acid Viscosupplementation
    • 1.1.1 Osteoarthritis
    • 1.1.2 Rheumatoid Arthritis
    • 1.1.3 Hyaluronic Acid Viscosupplementation
  • 1.2 Bone Graft Overview
    • 1.2.1 Autograft
    • 1.2.2 NP Allograft
    • 1.2.3 Demineralized Bone Matrix
    • 1.2.4 Synthetics
    • 1.2.5 Growth Factors
    • 1.2.6 Orthopedic Stem Cell Products
    • 1.2.7 BGS Applications

2.0 JAPANESE ORTHOPEDIC BIOMATERIAL MARKET

  • 2.1 Market Overview
  • 2.2 Country Overview
    • 2.2.1 Demographics
    • 2.2.2 Reimbursement Issues
    • 2.2.3 Pharmaceutical Affairs Law
  • 2.3 Market Analysis
    • 2.3.1 Market Forecast
  • 2.4 Competitive Analysis

3.0 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Procedures
    • 3.2.2 Market Forecast
    • 3.2.3 Market Drivers, Limiters, and Trends
      • 3.2.3.1 Market Drivers
      • 3.2.3.2 Market Limiters
      • 3.2.3.3 Market Trends
  • 3.3 Competitive Analysis

4.0 BONE GRAFT SUBSTITUTE MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Procedures
      • 4.2.1.1 By Material
      • 4.2.1.2 By Application
    • 4.2.2 Market Forecast
    • 4.2.3 Market Drivers and Limiters
      • 4.2.3.1 Market Drivers
      • 4.2.3.2 Market Limiters
  • 4.3 Competitive Analysis

APPENDIX: MRG ACRONYMS AND INITIALISMS

List of Exhibits

EXECUTIVE SUMMARY

  • Exhibit 1: Orthopedic Biomaterial Market, Japan (US$), 2006-2012
  • Exhibit 2: HA Viscosupplementation Treatments, Japan, 2006-2012
  • Exhibit 3: BGS Market, by Application, Japan (US$), 2006-2012
  • Exhibit 4: Leading Competitors in the Orthopedic Biomaterial Market, Japan, 2007

METHODOLOGY

  • Exhibit 5: Currency Exchange Rates, 2007

CHAPTER 1: ORTHOPEDIC BIOMATERIALS BACKGROUND

  • Exhibit 6: Select HA Viscosupplementation Companies and Products, Japan, 2007
  • Exhibit 7: Characteristics of Bone Graft Materials
  • Exhibit 8: Advantages and Disadvantages of Various Bone Graft Materials
  • Exhibit 9: Selected Synthetic BGS

CHAPTER 2: JAPANESE ORTHOPEDIC BIOMATERIAL MARKET

  • Exhibit 10: Orthopedic Biomaterial Market, Japan (US$), 2006-2012
  • Exhibit 11: Over-65 Cohort, as a % of Total Population, Japan, Europe, and US, 2005-2050
  • Exhibit 12: New Categorization of Medical Devices
  • Exhibit 13: Orthopedic Biomaterial Market, by Segment, Japan (US$), 2006-2012
  • Exhibit 14: Orthopedic Biomaterial Market, by Segment, Japan (¥), 2006-2012
  • Exhibit 15: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Japan, 2007
  • Exhibit 16: Leading Competitors in the Orthopedic Biomaterial Market, by Segment, as a % of Total, Japan, 2007

CHAPTER 3: HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Exhibit 17: HA Viscosupplementation Treatments, Japan, 2006-2012
  • Exhibit 18: HA Viscosupplementation Treatments and Injections, Japan, 2006- 2012
  • Exhibit 19: HA Viscosupplementation Market, Japan (US$), 2006-2012
  • Exhibit 20: HA Viscosupplementation Market, Japan (¥), 2006-2012
  • Exhibit 21: HA Viscosupplementation Market, by Type, Japan (US$), 2007
  • Exhibit 22: HA Viscosupplementation Market, by Type, Japan (US$ and ¥), 2007
  • Exhibit 23: Drivers, Limiters, and Trends of the HA Viscosupplementation Market, Japan
  • Exhibit 24: Leading Competitors in the HA Viscosupplementation Market, by Segment, as a % of Total, Japan, 2007

CHAPTER 4: BONE GRAFT SUBSTITUTE MARKET

  • Exhibit 25: BGS Market, by Application, Japan (US$), 2006-2012
  • Exhibit 26: Bone Graft Procedures, by Material, Japan, 2006-2012
  • Exhibit 27: Synthetic BGS Procedures, by Application, Japan, 2006-2012
  • Exhibit 28: Average Amount of Synthetic BGS Material Used, by Application, Japan, 2007
  • Exhibit 29: BGS Market, by Application, Japan (US$), 2006-2012
  • Exhibit 30: BGS Market, by Application, Japan (¥), 2006-2012
  • Exhibit 31: Joint Revision and Reconstruction BGS Market, Japan (US$), 2006-2012
  • Exhibit 32: Joint Revision and Reconstruction BGS Market, Japan (¥), 2006-2012
  • Exhibit 33: Trauma Surgery BGS Market, Japan (US$), 2006-2012
  • Exhibit 34: Trauma Surgery BGS Market, Japan (¥), 2006-2012
  • Exhibit 35: Spinal Fusion BGS Market, Japan (US$), 2006-2012
  • Exhibit 36: Spinal Fusion BGS Market, Japan (¥), 2006-2012
  • Exhibit 37: CMF Surgery BGS Market, Japan (US$), 2006-2012
  • Exhibit 38: CMF Surgery BGS Market, Japan (¥), 2006-2012
  • Exhibit 39: Drivers and Limiters of the BGS Market, Japan
  • Exhibit 40: Leading Competitors in the BGS Market, as a % of Total, Japan, 2007
Back to Top